Literature DB >> 21715676

Repaving the road to biomedical innovation through academia.

Andrew R Marks1.   

Abstract

Biomedical innovation requires investigators to build on existing knowledge and achieve insights that are transformative. Innovation starts with incisive scientific discoveries, which are often made in academic research laboratories. Today, the financial model for supporting biomedical research in universities is threatened, and one victim is innovation. New models for public funding that support high-risk research in academia will spur innovation and ultimately advance clinical medicine.

Entities:  

Mesh:

Year:  2011        PMID: 21715676      PMCID: PMC3690510          DOI: 10.1126/scitranslmed.3002223

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN: 1946-6234            Impact factor:   17.956


  4 in total

1.  Molecular structure of nucleic acids; a structure for deoxyribose nucleic acid.

Authors:  J D WATSON; F H CRICK
Journal:  Nature       Date:  1953-04-25       Impact factor: 49.962

2.  Molecular configuration in sodium thymonucleate.

Authors:  R E FRANKLIN; R G GOSLING
Journal:  Nature       Date:  1953-04-25       Impact factor: 49.962

3.  ON THE GERM THEORY.

Authors: 
Journal:  Science       Date:  1881-09-03       Impact factor: 47.728

4.  Classics in infectious diseases: on the antibacterial action of cultures of a penicillium, with special reference to their use in the isolation of B. influenzae by Alexander Fleming, Reprinted from the British Journal of Experimental Pathology 10:226-236, 1929.

Authors:  A Fleming
Journal:  Rev Infect Dis       Date:  1980 Jan-Feb
  4 in total
  1 in total

Review 1.  New Zealand's drug development industry.

Authors:  Michelle Marie Lockhart; Zaheer-Ud-Din Babar; Christopher Carswell; Sanjay Garg
Journal:  Int J Environ Res Public Health       Date:  2013-09-13       Impact factor: 3.390

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.